Location: Home > Pharma China Web Edition
  • search
  • go
  • News
  • 2/9/2026J&J Wins China Approval Expanding Subcutaneous Daratumumab Use
  • 2/9/2026InnoCare Wins China IND Clearance for VAV1 Molecular Glue Degrader ICP...
  • 2/9/2026BioKangtai Cancels Planned Vaccine Joint Venture With AstraZeneca in C...
  • 2/9/2026Roche and Henlius–Organon Resolve U.S. Patent Dispute Over Pertuzumab...
  • 2/9/2026Ascletis Begins U.S. Phase II Trial of Oral GLP-1R Agonist ASC30 for T...
  • 2/9/2026GenSci Advances Autoimmune Pipeline as NMPA Clears First IND for GenSc...
  • 2/9/2026Lilly Expands China Partnership With Innovent in New Global Oncology a...
  • 2/7/2026Recent Executive Moves
  • 2/7/2026Delonix Secures IND Clearance for Novel MenB Vaccine DX-104 in China ...
  • 2/7/2026Bio‑Thera and Avalon Forge 15‑Year Deal to Bring Keytruda Biosimilar...
  • 2/7/2026China Moves to Accelerate New Healthcare Insurance Models and Large‑S...
  • 2/6/2026Kelun-Biotech Expands Breast Cancer Indications of sac-TMT in China
  • 2/6/2026Genturn Life Raises CNY Tens of Millions in Angel Round to Advance Re...
  • 2/6/2026Merck's Keytruda Wins New China Approval for Frontline Endometrial Can...
  • 2/6/2026DCH Auriga Teams Up with Hengrui to Expand Innovative Medicines in HK ...
  • 2/6/2026Everest Medicines Gains Chinese Approval for VELSIPITY® in UC
  • 2/6/2026China Launches Nationwide Crackdown on BMI Fraud in Mental Health Sect...
  • 2/5/2026Novo Nordisk Reports First Decline in Ozempic Sales in Greater China
  • 2/5/2026Fosun Secures Priority Review in China for Luvometinib's New Indicatio...
  • 2/5/2026AmCham China Hosts US FDA Delegation to Strengthen Regulatory Dialogue
  • 2/5/2026Ascentage Secures China IND Clearance for Next-Gen BTK Degrader APG-32...
  • 2/5/2026Evogene and Lishan Biopharma Partner to Develop Microbiome Therapy for...
  • 2/5/2026Everest Medicines Licenses Micot's MT1013 for SHPT in China and Asia-P...
  • 2/5/2026Angitia Biopharma Raises $130M in Series D Financing to Advance Pipeli...
  • 2/5/2026Eisai Secures Exclusive Rights to Henlius' Anti-PD-1 Antibody Serpluli...
  • 2/5/2026iMBioRay Raises Nearly CNY 200M Series B to Advance NK Cell Therapy P...
  • 2/5/2026Shanghai Pharma Exits BMS China, Closing a Chapter for JV Pharma in Ch...
  • 2/5/20262026 National Conference on Drug Registration and Post-Market Regulati...
  • 2/5/2026CDE Issues Trial Guideline for Neuropathic Pain Drug Development
  • 2/5/2026CDE Issues Technical Guideline for Clinical Trials of Chronic Insomnia...
  • Page:9/61 Total number of articles:1822: [First][<<] [7] [8] [9] [10] [11] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group